325 related articles for article (PubMed ID: 31610847)
1. Metabolic stress is a primary pathogenic event in transgenic
Teo E; Ravi S; Barardo D; Kim HS; Fong S; Cazenave-Gassiot A; Tan TY; Ching J; Kovalik JP; Wenk MR; Gunawan R; Moore PK; Halliwell B; Tolwinski N; Gruber J
Elife; 2019 Oct; 8():. PubMed ID: 31610847
[TBL] [Abstract][Full Text] [Related]
2. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
[TBL] [Abstract][Full Text] [Related]
3. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
[TBL] [Abstract][Full Text] [Related]
4. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
5. β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
Wan L; Nie G; Zhang J; Luo Y; Zhang P; Zhang Z; Zhao B
Free Radic Biol Med; 2011 Jan; 50(1):122-9. PubMed ID: 21034809
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
Wang X; Yi K; Zhao Y
Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
[TBL] [Abstract][Full Text] [Related]
7. Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.
Ahmad W; Ebert PR
Mol Neurobiol; 2017 Sep; 54(7):5427-5439. PubMed ID: 27596506
[TBL] [Abstract][Full Text] [Related]
8. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
Godini R; Pocock R; Fallahi H
PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans.
Cogliati S; Clementi V; Francisco M; Crespo C; Argañaraz F; Grau R
J Alzheimers Dis; 2020; 73(3):1035-1052. PubMed ID: 31884470
[TBL] [Abstract][Full Text] [Related]
10. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
Shi YC; Pan TM; Liao VH
J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
12. A Caenorhabditis elegans model system for amylopathy study.
Duan Z; Sesti F
J Vis Exp; 2013 May; (75):e50435. PubMed ID: 23711592
[TBL] [Abstract][Full Text] [Related]
13. AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
Hassan WM; Merin DA; Fonte V; Link CD
Hum Mol Genet; 2009 Aug; 18(15):2739-47. PubMed ID: 19414486
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
15. Drug synergy as a strategy for compression of morbidity in a Caenorhabditis elegans model of Alzheimer's disease.
Teo E; Fong S; Tolwinski N; Gruber J
Geroscience; 2020 Jun; 42(3):849-856. PubMed ID: 32088829
[TBL] [Abstract][Full Text] [Related]
16. Carnosic acid ameliorated Aβ-mediated (amyloid-β peptide) toxicity, cholinergic dysfunction and mitochondrial defect in
Chen Y; Wang Y; Qin Q; Zhang Y; Xie L; Xiao J; Cao Y; Su Z; Chen Y
Food Funct; 2022 Apr; 13(8):4624-4640. PubMed ID: 35357374
[TBL] [Abstract][Full Text] [Related]
17. Vitexin prevents Aβ proteotoxicity in transgenic Caenorhabditis elegans model of Alzheimer's disease by modulating unfolded protein response.
Malar DS; Prasanth MI; Jeyakumar M; Balamurugan K; Devi KP
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22632. PubMed ID: 32926499
[TBL] [Abstract][Full Text] [Related]
18. Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.
Diomede L; Di Fede G; Romeo M; Bagnati R; Ghidoni R; Fiordaliso F; Salio M; Rossi A; Catania M; Paterlini A; Benussi L; Bastone A; Stravalaci M; Gobbi M; Tagliavini F; Salmona M
Neurobiol Dis; 2014 Feb; 62():521-32. PubMed ID: 24184799
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
20. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
